Edwards Lifesciences Corp. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,046
2,323
2,494
2,964
3,435
3,723
Cost of Goods Sold (COGS) incl. D&A
544
631
684
806
883
922
Gross Income
1,502
1,692
1,809
2,158
2,552
2,801
SG&A Expense
1,069
1,205
1,234
1,342
1,535
1,708
EBIT
433
487
-
816
1,017
1,092
Unusual Expense
-
82
731
65
3
314
Non Operating Income/Expense
2
59
57
6
16
16
Interest Expense
6
22
18
18
22
33
Pretax Income
515
1,144
622
738
1,035
761
Income Tax
124
333
128
168
451
39
Consolidated Net Income
392
811
495
570
584
722
Net Income
392
811
495
570
584
722
Net Income After Extraordinaries
392
811
495
570
584
722
Net Income Available to Common
392
811
495
570
584
722
EPS (Basic)
1.72
3.74
2.25
2.61
2.70
3.38
Basic Shares Outstanding
223
213
216
213
211
209
EPS (Diluted)
1.72
3.74
2.25
2.61
2.70
3.38
Diluted Shares Outstanding
228
217
220
218
216
214
EBITDA
502
556
642
887
1,099
1,170
Non-Operating Interest Income
5
6
8
11
20
32
About Edwards Lifesciences
View Profile
